The pneumococcal vaccine and the flu shot are two completely different vaccines that protect against two unrelated pathogens. The flu shot targets influenza viruses, while the pneumococcal vaccine targets the bacterium Streptococcus pneumoniae. The confusion is understandable because both vaccines defend the lungs, both tend to be recommended around the same time of year, and they are sometimes given during the same office visit. But they are not interchangeable, and getting one does not protect you against the disease the other covers.
What Each Vaccine Actually Does
Influenza vaccines work by training your immune system to recognize specific strains of the influenza virus. Because the flu virus mutates rapidly through a process called antigenic drift, new flu shots are formulated every year to match the strains most likely to circulate that season.1PubMed Central. Vaccination and antigenic drift in influenza That annual reformulation is why you hear about getting “this year’s flu shot” each fall.
Pneumococcal vaccines, by contrast, target the sugar coating on the surface of pneumococcal bacteria. The first versions, developed in the 1970s, used pieces of this coating directly, but they did not generate lasting immune memory. A newer generation of conjugate vaccines, introduced around 2000, link those sugar pieces to a protein carrier, which produces a stronger and longer-lasting response.2PubMed Central. Evaluating immune responses to pneumococcal vaccines Because S. pneumoniae does not mutate nearly as fast as influenza, pneumococcal vaccines do not need to be updated every year. Most adults only need one or two doses across their lifetime rather than an annual appointment.
So the practical difference is stark: the flu shot is annual and virus-targeted, while the pneumococcal vaccine is infrequent and bacteria-targeted. Substituting one for the other would leave you entirely unprotected against the disease you skipped.
Why People Mix Them Up
Several factors feed the confusion. Both vaccines are routinely offered in autumn at pharmacies and primary-care offices, often side by side in promotional signage. Both protect the respiratory system. And doctors sometimes recommend them at the same visit, especially for older adults, which can make it feel like a single bundled event rather than two distinct medical interventions.
There is also a perception gap. A study of adults in Hong Kong found that people who had previously received the flu vaccine were roughly three times as willing to accept the pneumococcal vaccine, suggesting that many people lump respiratory vaccines together in their minds and may not clearly distinguish what each one is for.3PubMed Central / Vaccine. Factors associated with willingness among adults to receive pneumococcal vaccine in Hong Kong: a cross-sectional study using HBM constructs Meanwhile, a U.S. study of high-risk adults aged 19 to 64 found that only about 45% were up to date on pneumococcal vaccination, even though the majority had completed a primary COVID-19 vaccine series, hinting that people do not always realize pneumococcal vaccination applies to them.4Chest. Disparities in Influenza, Pneumococcal, COVID-19 Vaccine Coverage in High-Risk Adults Aged 19 to 64 Years in Southeastern Minnesota, 2010-2021
How Flu and Pneumococcal Disease Are Biologically Connected
Even though the vaccines are different, the diseases they prevent are deeply intertwined, and that connection is one more reason the two get tangled in people’s minds. An influenza infection can set the stage for a secondary pneumococcal infection in ways that make the combination far more dangerous than either pathogen alone.
When the flu virus infects the respiratory tract, it damages the lining of the airways and kills epithelial cells. That damage weakens the physical barrier that normally keeps bacteria out. Influenza can also activate inflammatory pathways that loosen the tight junctions between cells, further compromising the lung’s defenses.5Journal of Infection and Public Health. PostInfluenza bacterial infections: Epidemiology, mechanistic insights and emerging treatment approaches With the barrier broken, pneumococcal bacteria that might otherwise sit harmlessly in the nose and throat can invade deeper tissue and cause pneumonia, bloodstream infections, or meningitis.6Europe PMC. Insights into the interaction between influenza virus and pneumococcus
The immune system itself gets thrown off balance. During flu infection, the body ramps up type I interferons to fight the virus. But research in mice has shown that those same interferons suppress a subset of immune cells that are critical for clearing pneumococcal bacteria from the lungs. Mice that lacked the receptor for type I interferons were actually better at fighting off a secondary pneumococcal infection because their bacterial-clearing immune cells stayed functional.7PubMed Central. Type I interferon induction during influenza virus infection increases susceptibility to secondary Streptococcus pneumoniae infection by negative regulation of γδ T cells In other words, the immune response that helps fight the flu can inadvertently open the door to a deadly bacterial follow-up.
This pattern is not just a laboratory curiosity. During the 1918 influenza pandemic, secondary bacterial pneumonia following influenza was the overwhelming cause of death, not the viral infection itself.8PubMed. Insights from unusual aspects of the 1918 influenza pandemic That historical reality underscores why protecting against both pathogens matters, and why getting only one of these vaccines leaves a real gap.
Can You Get Both Vaccines at the Same Visit?
Yes, and the evidence consistently shows it is safe and effective to receive both at the same appointment. An early study in elderly individuals found no side effects in the vaccinated population and confirmed that flu vaccine antibody levels were not diminished by simultaneous pneumococcal vaccination.9PubMed. Simultaneous influenza and pneumococcal vaccination in elderly individuals A larger study of over 800 participants found that local reactions like redness at the injection site were slightly more common when both vaccines were given together, but the reactions were mild and resolved quickly. No serious adverse events were reported.10PubMed. Reactions after pneumococcal vaccine alone or in combination with influenza vaccine
A trial specifically testing an adjuvanted flu vaccine alongside the 23-valent pneumococcal polysaccharide vaccine in older adults confirmed that both vaccines met their immunogenicity targets when given at the same time. The immune response to the flu vaccine was unaffected regardless of whether the pneumococcal shot was given in the same arm or the opposite arm. Pneumococcal antibody responses also increased substantially after vaccination, regardless of the concurrent flu shot.11PubMed. Immunogenicity and safety of concomitant MF59-adjuvanted influenza vaccine and 23-valent pneumococcal polysaccharide vaccine administration in older adults The bottom line is that there is no medical reason to schedule separate visits for these two vaccines. If your doctor or pharmacist offers both, taking them together saves you a trip without sacrificing protection.
Who Needs Which Vaccine, and When
The schedules for these vaccines are fundamentally different, which is another area where confusion creeps in. The flu shot is recommended annually for almost everyone aged six months and older. You get it every autumn because the circulating strains change. The pneumococcal vaccine, on the other hand, follows a more complex schedule based on age and medical risk.
Young children receive a series of pneumococcal conjugate vaccine doses in infancy and toddlerhood. Healthy adults typically do not need a pneumococcal vaccine until age 65, at which point current U.S. guidelines recommend a conjugate vaccine dose followed, in some cases, by a polysaccharide booster. But adults of any age with certain chronic conditions are recommended to receive pneumococcal vaccination earlier. That is where the schedules can overlap: a 50-year-old with COPD, for instance, should be up to date on both vaccines, not just the flu shot.
The immune responses also differ by age group. Research has shown that after a single dose of conjugate vaccine, toddlers mount a weaker polysaccharide-specific response than adults, with their antibodies dominated by an early-stage type rather than the more mature form seen in adult immune responses.12PubMed Central. Serotype-specific and age-dependent generation of pneumococcal polysaccharide-specific memory B-cell and antibody responses to immunization with a pneumococcal conjugate vaccine That is partly why children need multiple doses spaced out over months, while adults can often get by with fewer.
People at Higher Risk for Pneumococcal Disease
The flu puts nearly everyone at some level of risk every winter, but pneumococcal disease hits certain groups disproportionately hard. People with chronic obstructive pulmonary disease (COPD) face roughly double the risk of invasive pneumococcal disease compared to the general population, and chronic liver disease carries a similar increase in risk.13PubMed. Risk of underlying chronic medical conditions for invasive pneumococcal disease in adults The danger compounds with multiple conditions: someone with three or more chronic medical conditions faces about five times the risk of an otherwise healthy person.
Smoking, asthma, diabetes, and chronic heart disease all independently raise the risk of pneumococcal pneumonia and can worsen outcomes after infection, including both short-term and long-term mortality.14PubMed Central. Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal disease For people with COPD specifically, both pneumococcal and influenza vaccination have been shown to reduce community-acquired pneumonia and acute exacerbations, with evidence suggesting that pneumococcal vaccination early in the course of the disease helps maintain stable health over time.15PubMed Central. Pneumococcal vaccination and chronic respiratory diseases
This is one of the practical takeaways that gets lost when people conflate the two vaccines. If you have a chronic lung or heart condition, diabetes, or you smoke, you likely need pneumococcal vaccination well before age 65. Relying only on the annual flu shot leaves a significant gap in your respiratory protection.
The Seasonal Connection That Reinforces the Confusion
Pneumococcal disease peaks in winter, just like the flu, which makes it easy to assume the two are part of the same illness. But the seasonal pattern of pneumococcal infections is driven by multiple factors, not just influenza. Pneumococcal pneumonia incidence peaks in late winter, while other forms of invasive pneumococcal disease peak in autumn, before flu season even hits full stride.16PubMed Central. Seasonal Drivers of Pneumococcal Disease Incidence: Impact of Bacterial Carriage and Viral Activity
That said, the overlap is real. Studies have found that the weekly frequency of invasive pneumococcal disease directly correlates with the circulation of both influenza and respiratory syncytial virus (RSV). The average rate of invasive pneumococcal disease during flu and RSV seasons is measurably higher than during periods when those viruses are not circulating.17PubMed. Seasonality of invasive pneumococcal disease: temporal relation to documented influenza and respiratory syncytial viral circulation Among older adults, pneumococcal disease shows a broad winter curve with a notable spike around the holiday season in late December.18European Respiratory Journal. Pneumococcal disease seasonality: incidence, severity and the role of influenza activity
The seasonal alignment makes biological sense given what we know about flu weakening the lung’s defenses against bacteria. It also reinforces the practical argument for getting both vaccines before winter: if flu season amplifies pneumococcal disease, then protection against both pathogens simultaneously gives you the best odds of staying healthy through the highest-risk months.
Herd Effects Work Differently for Each Vaccine
One area where these vaccines diverge in interesting ways is how they benefit people who are not vaccinated. Childhood pneumococcal conjugate vaccination has produced substantial herd protection for older, unvaccinated age groups. Modeling of the early years after the seven-valent pneumococcal conjugate vaccine was introduced for U.S. children showed that invasive disease caused by the vaccine-targeted strains dropped sharply in unvaccinated adults as well, because vaccinated children stopped carrying and transmitting those strains.19PubMed. Herd immunity and pneumococcal conjugate vaccine: a quantitative model
The flu shot, by contrast, generates more modest herd effects. Because influenza mutates so quickly and vaccine effectiveness varies from year to year, the indirect protection for unvaccinated individuals is less consistent and harder to sustain. You cannot rely on the people around you getting their flu shot to keep you safe the way you might benefit indirectly from childhood pneumococcal vaccination programs.
Serotype Replacement and the Evolving Landscape
Pneumococcal vaccines face a challenge the flu shot does not: serotype replacement. S. pneumoniae comes in roughly 100 different serotypes, and current vaccines only cover a subset. When a vaccine succeeds in driving down the targeted strains, non-vaccine serotypes can fill the ecological gap. Studies have found that among asymptomatic carriers, non-vaccine serotypes increased substantially after widespread conjugate vaccination, and in many populations, disease caused by those non-vaccine types has risen as well.20PubMed Central. Serotype replacement in disease after pneumococcal vaccination
Research in Tanzania illustrates the shift concretely. Before the 13-valent pneumococcal conjugate vaccine was introduced, about 55% of pneumococcal strains found in young children were vaccine types. After the vaccine rollout, that dropped to roughly 23%, and 14 non-vaccine serotypes emerged that had not been detected at all in the pre-vaccine period.21PubMed Central. Emergence of non-vaccine Streptococcus pneumoniae serotypes colonizing the nasopharynx of children under five years of age in the 13-valent pneumococcal conjugate vaccine era in Tanzania In New Zealand, where the national immunization program switched from a 13-valent to a 10-valent conjugate vaccine in 2017, serotype 19A (covered by the 13-valent but not the 10-valent vaccine) surged to account for about 59% of all invasive pneumococcal disease cases in children under five by 2022.22The Lancet Regional Health – Western Pacific. Invasive pneumococcal disease in Aotearoa New Zealand following conjugate vaccine changes: a descriptive and genomic-epidemiological investigation
This is a fundamentally different problem from the one the flu shot faces. Influenza vaccines must be updated annually because the virus itself mutates to evade immunity. Pneumococcal vaccines are stable against their targeted strains, but the bacterial population shifts around them. The response from vaccine developers has been to keep expanding the number of serotypes covered: newer formulations now target 15 or 20 serotypes, up from the original seven. It is an ongoing arms race, but a slower-moving one than the annual sprint of flu vaccine reformulation.
Side Effects Compared
People sometimes worry about stacking side effects if they get both vaccines at once. In practice, side effects from either vaccine are typically mild. The most common reactions to both are soreness, redness, or swelling at the injection site, along with occasional low-grade fever or muscle aches.
One distinction worth knowing: pneumococcal vaccines tend to cause more noticeable local reactions than standard flu shots. The trial of simultaneous administration in older adults found that local and systemic side effects were more common in people receiving the pneumococcal vaccine compared to those getting only the flu shot.11PubMed. Immunogenicity and safety of concomitant MF59-adjuvanted influenza vaccine and 23-valent pneumococcal polysaccharide vaccine administration in older adults Among flu vaccines specifically, high-dose formulations designed for older adults produce more side effects than standard doses. One comparison found that about 37% of high-dose recipients reported a local or systemic side effect versus 22% of standard-dose recipients, though severe reactions were rare in both groups.23Oxford Academic (Open Forum Infectious Diseases). Comparison of Side Effects of the 2015-2016 High-Dose, Inactivated, Trivalent Influenza Vaccine and Standard Dose, Inactivated, Trivalent Influenza Vaccine in Adults ≥65 Years
If you do get both on the same day, you can ask for them in different arms, which makes it easier to tell which vaccine is responsible if one injection site gets sore. But the research is reassuring that getting both simultaneously does not create some compounded reaction above what you would expect from each vaccine individually.